Bandingkan Harga & Kinerja Merck Tbk. (MERK) vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF (XBIG)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Merck Tbk. dan Reksa Dana Indeks BNP Paribas IDX Growth30 ETF: Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb), sedangkan Reksa Dana Indeks BNP Paribas IDX Growth30 ETF diperdagangkan di Rp600 (kapitalisasi pasar 120 jt). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 14666,7× kapitalisasi pasar Reksa Dana Indeks BNP Paribas IDX Growth30 ETF. Mana yang lebih baik tergantung tujuan investasimu.
| MERK | XBIG | |
|---|---|---|
Kapitalisasi Pasar | 1,76 T | 120 jt |
Volume | 63 rb | — |
Lot | 630 | — |
Perputaran | 243,97 jt | — |
Harga Rata-rata | 3.872,46 | — |
Nilai Transaksi | 243,97 jt | — |
Harga Ekuilibrium Indikatif | 3.900 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →
